Ticker Information
Ticker
DHRCompany Name
DANAHER CORPSector
HealthcareIndustry
Diagnostics & ResearchExchange
NYSEDANAHER CORP - Capital Expenditure Chart Analysis (TTM)
Date Range
Zoom
DHR - Capital Expenditure Historical Data
| Date | Capital Expenditure |
|---|---|
| 2026-06-30 | $ 1.15B |
| 2026-03-31 | $ 1.12B |
| 2025-12-31 | $ 1.12B |
| 2025-09-30 | $ 1.29B |
| 2025-06-30 | $ 1.28B |
| 2025-03-31 | $ 1.33B |
| 2024-12-31 | $ 1.38B |
| 2024-09-30 | $ 1.26B |
| 2024-06-30 | $ 1.34B |
| 2024-03-31 | $ 1.39B |
Key Performance Insights, Last 5 Years
- ✓ DANAHER CORP's latest trailing twelve months (TTM) CapEx stands at $ 1.15B.
- ✓ Over the past 5 years, DANAHER CORP's average CapEx has been $ 1.26B.
- ✓ The median CapEx for DANAHER CORP during this period was $ 1.28B
- ✓ DANAHER CORP reached its highest CapEx over the past 5 years at $ 1.39B.
- ✓ The lowest CapEx recorded by DANAHER CORP in the same timeframe $ 1.12B
DANAHER CORP's CapEx vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx Benchmarks
| Company | CapEx |
|---|---|
| SYK : STRYKER CORP | $ 804M |
| IQV : IQVIA HOLDINGS INC | $ 560M |
| GILD : GILEAD SCIENCES INC | $ 576M |
| BSX : BOSTON SCIENTIFIC CORP | $ 866M |
| ISRG : INTUITIVE SURGICAL INC | $ 437.8M |
| TMO : THERMO FISHER SCIENTIFIC INC | $ 1.5B |
| MDT : MEDTRONIC PLC | $ 1.9B |
| VRTX : VERTEX PHARMACEUTICALS INC | $ 530.3M |
| LH : LABCORP HOLDINGS INC | $ 429.5M |
| DGX : QUEST DIAGNOSTICS INC | $ 554M |
Similar metrics to CapEx:
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Property Plant & Equipment (Net) - [Balance Sheet] A component of [Assets] representing the assets that are either property, plant or equipment after accumulated depreciation, depletion and amortization. Common examples include buildings, land, furniture, and other physical assets that a company has purchased to run its business.
Definition of Capital Expenditure
[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
DHR - Capital Expenditure, Last 5 years
Minimum
Mar 31, 2026
Maximum
Mar 31, 2024
Average
Median
CapEx Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.96M with a standard deviation of $ 16.46M.
The following table provides additional summary stats:
CapEx in the Market:
| filtered constituents | 2.88K |
|---|---|
| min | $ -43.7M |
| max | $ 66.4M |
| average | $ 9.96M |
| median | $ 1.75M |
| std | $ 16.46M |